Yale University: HIV Infections trials

The registry lists 24 HIV Infections studies with Yale University as lead sponsor. 0 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 5Phase 2 2Phase 3 1Phase 4 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The LEARN Study for CVD PreventionCompletedNCT05242952Not applicableResults posted
• Project SMART Automated Pillbox StudyCompletedNCT04418076Not applicableResults posted
• A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV RiskCompletedNCT02929069Not applicableResults posted
• HIV, Buprenorphine, and the Criminal Justice SystemCompletedNCT01550341Not applicableResults posted
• Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice PopulationsCompletedNCT01246401Phase 1/2Results posted
• Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and PreventionCompletedNCT01227044Phase 2/3Results posted
• Alcohol Pharmacotherapy for HIV+ PrisonersCompletedNCT01077310Not applicableResults posted
• Buprenorphine/Raltegravir Pharmacokinetic Interaction StudyCompletedNCT00858962Not applicableResults posted
• Pilot Study of a Raltegravir Based NRTI Sparing RegimenCompletedNCT00814879Not applicableResults posted
• Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)CompletedNCT00571961Not applicableResults posted
• Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/RitonavirCompletedNCT00486330Not applicableResults posted
• Buprenorphine Integration Research and Community HealthActive, not recruitingNCT05668780Not applicable
• An AI-based mHealth Intervention to Improve HIV TestingCompletedNCT05335096Not applicable
• In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected HumansCompletedNCT04920539Phase 1
• Developing a Chatbot to Promote HIV TestingCompletedNCT04910984
• HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)CompletedNCT03583138
• Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk NetworksCompletedNCT03293290Phase 1
• Intervention to Encourage HIV Testing and Counseling Among AdolescentsCompletedNCT02812329Phase 1
• Intervention Development for Social Stress, Mental Health, and HIV Risk MSMCompletedNCT02448186Not applicable
• Intervention of HIV, Drug Use and the Criminal Justice System in MalaysiaCompletedNCT02396979Phase 4
• Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionCompletedNCT02170246Phase 1
• Positive Lifestyles Using SafetyCompletedNCT00836290Not applicable
• Early Versus Delayed Routine HIV Testing in Connecticut JailsCompletedNCT00624247Early Phase 1
• Buprenorphine and Integrated HIV CareCompletedNCT00317460Phase 4